Kadmon Holdings Return on Equity

Kadmon Holdings (KDMN) currently reports a ROE of -911.29%. That is below the Healthcare sector average of 21.67%. Use the charts on this page to explore Kadmon Holdings's ROE history and peer comparisons.

Kadmon Holdings's ROE of -911.29% is lower than the Healthcare sector average of 21.67%. That is roughly 4305.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Kadmon Holdings's current -911.29% should be judged against Healthcare norms (sector average: 21.67%) and against KDMN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -911.29%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.67%. From there, open related valuation or income-statement pages for Kadmon Holdings, and consider following KDMN for alerts when major investors trade the stock.

Kadmon Holdings is classified in the Healthcare sector. On ROE, it currently shows -911.29% versus a sector average near 21.67%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KDMN with unrelated industries.